ProfileGDS4095 / 220397_at
TitleTamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OrganismHomo sapiens


SRC1 knockdown control tamoxifen untreated tamoxifen untreated GSM709767 GSM709769 GSM709765 GSM709771 GSM709772 GSM709775 GSM709764 GSM709766 GSM709768 GSM709777 GSM709770 GSM709773 GSM709774 GSM709776 73% 74% 75% 76% 75% 75% 76% 77% 75% 77% 75% 76% 75% 75% sort by genotype/variation sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM709767LY2 SRC1-siRNA tamoxifen treated rep17.5114473
GSM709769LY2 SRC1-siRNA tamoxifen treated rep37.5508674
GSM709765LY2 SRC1-siRNA untreated rep37.8342375
GSM709771LY2 SRC1-siRNA untreated rep17.9619476
GSM709772LY2 SRC1-siRNA untreated rep27.8064975
GSM709775LY2 SRC1-siRNA untreated rep47.8382175
GSM709764LY2 control-siRNA tamoxifen treated rep28.0714676
GSM709766LY2 control-siRNA tamoxifen treated rep38.2016477
GSM709768LY2 control-siRNA tamoxifen treated rep17.8964875
GSM709777LY2 control-siRNA tamoxifen treated rep48.1796777
GSM709770LY2 control-siRNA untreated rep37.8244875
GSM709773LY2 control-siRNA untreated rep17.9530276
GSM709774LY2 control-siRNA untreated rep27.9177875
GSM709776LY2 control-siRNA untreated rep47.8732575